Forward Science Technologies Launches Liquid-Cytology Testing to Dental Industry
Forward Science Technologies is the first American company to incorporate fluorescence technology and liquid-based cytology to enhance the oral health assessment
By: Forward Science Technologies LLC
"OralID users have been asking us to develop a test for suspicious tissue highlighted by the fluorescence technology,"
CytID is the first cytology product targeting oral cancer screening that can also facilitate HPV testing of suspicious samples. Further, collecting a cytology sample with CytID is less painful for the patient, simple for the clinician, and the result can provide peace of mind to patients - or early detection should harmful conditions exist.
"We have been testing ClearPrep for oral screening for some time," explained Michael Friedl, President & CEO of Resolution Biomedical. "Because of their depth of experience in the dental market, partnering with Forward Science Technologies has been a natural fit for us. We have high hopes for CytID."
About Forward Science Technologies LLC
Forward Science Technologies manufactures and markets the OralID, a fluorescence based screening device, which highlights oral mucosal abnormalities including cancerous and dysplastic lesions. The kit includes the SmartFilterID for clinical photo documentation, a two year warranty, and free lifetime Team Training. The OralID kit is priced less than one-half of the other fluorescence based oral cancer screening devices on the market, and is the only device that requires no disposables. For more information, visit www.cyt-id.com
About Resolution Biomedical, Inc.
Resolution Biomedical is headquartered in Tustin California, and has developed ClearPrep, which has been validated for all types of cytological preparations in laboratories in the US, Europe, Asia, Africa and South America. For more information, visit www.resolutionbiomedical.com